Literature DB >> 28817552

Effects of Antiretroviral Therapy to Prevent HIV Transmission to Women in Couples Attempting Conception When the Man Has HIV Infection - United States, 2017.

John T Brooks, Jennifer F Kawwass, Dawn K Smith, Dmitry M Kissin, Margaret Lampe, Lisa B Haddad, Sheree L Boulet, Denise J Jamieson.   

Abstract

Existing U.S. guidelines recommend that men with human immunodeficiency virus (HIV) infection should achieve virologic suppression* with effective antiretroviral therapy (ART) before attempting conception (1). Clinical studies have demonstrated that effective ART profoundly reduces the risk for HIV transmission (2-4). This information might be useful for counseling couples planning a pregnancy in which the man has HIV infection and the woman does not (i.e., a mixed HIV-status couple, often referred to as a serodiscordant couple).

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28817552      PMCID: PMC5657665          DOI: 10.15585/mmwr.mm6632e1

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


Existing U.S. guidelines recommend that men with human immunodeficiency virus (HIV) infection should achieve virologic suppression* with effective antiretroviral therapy (ART) before attempting conception (). Clinical studies have demonstrated that effective ART profoundly reduces the risk for HIV transmission (–). This information might be useful for counseling couples planning a pregnancy in which the man has HIV infection and the woman does not (i.e., a mixed HIV-status couple, often referred to as a serodiscordant couple). The risk for male-to-female sexual transmission of HIV in the absence of any prevention measures is estimated to be approximately 8 per 10,000 episodes of condomless intercourse (95% confidence intervals = 6–11) (). Three multinational studies, HPTN 052 (), PARTNER (), and Opposites Attract (), have provided data regarding the effectiveness of suppressing HIV replication with ART to reduce the risk for sexual HIV transmission. These studies followed approximately 3,000 sexually active mixed HIV-status couples over many years while they did not use condoms. The PARTNER and Opposites Attract studies quantified the extent of sexual exposure; 548 heterosexual couples (269 [49%] with a male HIV-infected partner) and 658 male-male couples from 14 European countries, Australia, Brazil, and Thailand engaged in >74,000 condomless episodes of vaginal or anal intercourse during >1,500 couple-years of observation (,). All three studies observed no HIV transmission to the uninfected partner while the partner with HIV was virologically suppressed with ART (–). Recent studies have shown that men taking ART who have no detectable HIV RNA in their peripheral blood can occasionally have HIV genetic material detected in their semen (6–8). As many as 25% of men have had HIV RNA detected in semen after 3 months of viral suppression (6). After 4 or more months of suppression, reported detection rates in semen have been 5%–6% (8). In these studies, semen HIV RNA concentrations were 59–2,560 copies/mL (6–8). It is not known whether such detection represents the presence of replicating virus at sufficient concentration to transmit infection. HPTN 052, PARTNER, and Opposite Attract have not reported data on HIV RNA detection in semen; however, in the context of the above-cited information, it is possible HIV RNA could have been present in some semen specimens but that concentrations of replication competent virus were insufficient to transmit infection (2–4). Mixed HIV-status couples attempting conception can also reduce the risk for sexually transmitting HIV by decreasing the frequency of sexual contact and limiting condomless intercourse to the time of ovulation. Preexposure prophylaxis (PrEP), a highly effective HIV prevention method in which the partner without HIV takes antiretrovirals in advance of potential HIV exposure (), can also reduce the risk for a woman who is attempting conception with an HIV-infected man, especially if his viral load is not known or is detectable (). Semen processing with subsequent intrauterine insemination (IUI) or in vitro fertilization (IVF) also significantly and substantially reduces transmission of HIV from men to women (). For some couples, semen processing combined with IUI or IVF might be an option, especially if fertility treatment is needed or if the man’s HIV viral load cannot be fully suppressed. The extent to which any of these preventive interventions further decreases HIV risk below that associated with viral suppression and an undetectable viral load is unknown. It is important that health care providers regularly assess mixed HIV-status couples’ plans for conception. Considering factors such as risk tolerance, personal health, costs, and access to health care services, providers can help couples make the best decision for their personal circumstances.
  7 in total

1.  Seminal HIV-1 RNA Detection in Heterosexual African Men Initiating Antiretroviral Therapy.

Authors:  Andrew Mujugira; Robert W Coombs; Renee Heffron; Connie Celum; Allan Ronald; Nelly Mugo; Jared M Baeten
Journal:  J Infect Dis       Date:  2016-04-06       Impact factor: 5.226

2.  Highly active antiretroviral therapy does not completely suppress HIV in semen of sexually active HIV-infected men who have sex with men.

Authors:  Joseph A Politch; Kenneth H Mayer; Seth L Welles; William X O'Brien; Chong Xu; Frederick P Bowman; Deborah J Anderson
Journal:  AIDS       Date:  2012-07-31       Impact factor: 4.177

3.  HIV-1 is undetectable in preejaculatory secretions from HIV-1-infected men on suppressive HAART.

Authors:  Joseph A Politch; Kenneth H Mayer; Deborah J Anderson
Journal:  AIDS       Date:  2016-07-31       Impact factor: 4.177

4.  Antiretroviral Therapy for the Prevention of HIV-1 Transmission.

Authors:  Myron S Cohen; Ying Q Chen; Marybeth McCauley; Theresa Gamble; Mina C Hosseinipour; Nagalingeswaran Kumarasamy; James G Hakim; Johnstone Kumwenda; Beatriz Grinsztejn; Jose H S Pilotto; Sheela V Godbole; Suwat Chariyalertsak; Breno R Santos; Kenneth H Mayer; Irving F Hoffman; Susan H Eshleman; Estelle Piwowar-Manning; Leslie Cottle; Xinyi C Zhang; Joseph Makhema; Lisa A Mills; Ravindre Panchia; Sharlaa Faesen; Joseph Eron; Joel Gallant; Diane Havlir; Susan Swindells; Vanessa Elharrar; David Burns; Taha E Taha; Karin Nielsen-Saines; David D Celentano; Max Essex; Sarah E Hudelson; Andrew D Redd; Thomas R Fleming
Journal:  N Engl J Med       Date:  2016-07-18       Impact factor: 91.245

5.  Sexual Activity Without Condoms and Risk of HIV Transmission in Serodifferent Couples When the HIV-Positive Partner Is Using Suppressive Antiretroviral Therapy.

Authors:  Alison J Rodger; Valentina Cambiano; Tina Bruun; Pietro Vernazza; Simon Collins; Jan van Lunzen; Giulio Maria Corbelli; Vicente Estrada; Anna Maria Geretti; Apostolos Beloukas; David Asboe; Pompeyo Viciana; Félix Gutiérrez; Bonaventura Clotet; Christian Pradier; Jan Gerstoft; Rainer Weber; Katarina Westling; Gilles Wandeler; Jan M Prins; Armin Rieger; Marcel Stoeckle; Tim Kümmerle; Teresa Bini; Adriana Ammassari; Richard Gilson; Ivanka Krznaric; Matti Ristola; Robert Zangerle; Pia Handberg; Antonio Antela; Sris Allan; Andrew N Phillips; Jens Lundgren
Journal:  JAMA       Date:  2016-07-12       Impact factor: 56.272

Review 6.  Strategies for Preventing HIV Infection Among HIV-Uninfected Women Attempting Conception with HIV-Infected Men - United States.

Authors:  Jennifer F Kawwass; Dawn K Smith; Dmitry M Kissin; Lisa B Haddad; Sheree L Boulet; Saswati Sunderam; Denise J Jamieson
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2017-06-02       Impact factor: 17.586

Review 7.  Heterosexual risk of HIV-1 infection per sexual act: systematic review and meta-analysis of observational studies.

Authors:  Marie-Claude Boily; Rebecca F Baggaley; Lei Wang; Benoit Masse; Richard G White; Richard J Hayes; Michel Alary
Journal:  Lancet Infect Dis       Date:  2009-02       Impact factor: 25.071

  7 in total
  2 in total

1.  Models of HIV Preconception Care and Key Elements Influencing These Services: Findings from Healthcare Providers in Seven US Cities.

Authors:  Joanne Simone; Mary Jo Hoyt; Deborah S Storm; Sarah Finocchario-Kessler
Journal:  AIDS Patient Care STDS       Date:  2018-06-05       Impact factor: 5.078

2.  Retroviruses and reproduction revisited.

Authors:  Ann A Kiessling
Journal:  J Assist Reprod Genet       Date:  2018-07-13       Impact factor: 3.412

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.